Renewed and expanded Ornge fleet will better connect patients in rural and remote areas to urgent care SUDBURY — The Ontario government is investing over $108 million to expand Ornge Air Ambulance’s fixed wing fleet with four additional state-of-the-art planes and replace their existing eight fixed wing fleet. This investment will ensure Ornge’s air ambulance service can continue to provide …
London – AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season, and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. Beyfortus will be available …
